CYP2B6 c.172-1162G>A

Variant ID: 19-41508744-G-A

NM_000767.4(CYP2B6):c.172-1162G>A

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid.

Southern African Journal Of Hiv Medicine
Decloedt, Eric H EH; Sinxadi, Phumla Z PZ; Wiesner, Lubbe L; Joska, John A JA; Haas, David W DW; Maartens, Gary G
Publication Date: 2021

Variant appearance in text: rs11672911
PubMed Link: 34007475
Variant Present in the following documents:
  • Main text
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs11672911
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Genetic variation in the CYP2B6 gene is related to circulating 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) concentrations: an observational population-based study.

Environmental Health : A Global Access Science Source
Penell, Johanna J; Lind, Lars L; Fall, Tove T; Syvänen, Anne-Christine AC; Axelsson, Tomas T; Lundmark, Per P; Morris, Andrew P AP; Lindgren, Cecilia C; Mahajan, Anubha A; Salihovic, Samira S; van Bavel, Bert B; Ingelsson, Erik E; Lind, P Monica PM
Publication Date: 2014-05-08

Variant appearance in text: rs11672911
PubMed Link: 24885815
Variant Present in the following documents:
  • Main text
  • 1476-069X-13-34.pdf
View BVdb publication page